Application to the PBAC July 2024 Agenda for the Subsidy of Lecanemab and Esketamine

Submission Last updated: Jun 2024 Published in Australia Reference: 07AUS

RANZCP Submission to the Pharmaceutical Benefits Advisory Committee (PBAC) regarding the Application to the PBAC July 2024 Agenda for the Subsidy of Lecanemab and Esketamine

Resources

RANZCP-Submission-Application-to-the-PBAC-July-2024-Agenda-for-the-subsidy-of-Lecanemab-and-Esketamine

PDF (303 KB)